U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H13N3O2
Molecular Weight 207.2291
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUANOXAN

SMILES

NC(=N)NCC1COC2=C(O1)C=CC=C2

InChI

InChIKey=HIUVKVDQFXDZHU-UHFFFAOYSA-N
InChI=1S/C10H13N3O2/c11-10(12)13-5-7-6-14-8-3-1-2-4-9(8)15-7/h1-4,7H,5-6H2,(H4,11,12,13)

HIDE SMILES / InChI

Molecular Formula C10H13N3O2
Molecular Weight 207.2291
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Guanoxan is 2-guanidinomethylbenzo-1,4-dioxan. It acts as a blocker of alpha-2 adrenoceptors. The clinical use of this drug has been in the treatment of hypertension. Both systolic and diastolic pressures are lowered in the lying and standing positions.

Approval Year

PubMed

PubMed

TitleDatePubMed

Sample Use Guides

The drug may be given orally initially at a dose of 20 mg. daily and doubled every fourth day until an effect is obtained. Where more rapid effect is desired, a loading dose of 40 mg. may be used.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:29:41 GMT 2023
Edited
by admin
on Fri Dec 15 17:29:41 GMT 2023
Record UNII
9V0MRL0R5Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GUANOXAN
INN   MI   WHO-DD  
INN  
Official Name English
Guanoxan [WHO-DD]
Common Name English
GUANOXAN [MI]
Common Name English
guanoxan [INN]
Common Name English
GUANIDINE, (2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLMETHYL)-
Systematic Name English
Classification Tree Code System Code
WHO-ATC C02CC03
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
WHO-VATC QC02CC03
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
Code System Code Type Description
DRUG CENTRAL
1346
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
ChEMBL
CHEMBL76725
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
MESH
C073344
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
INN
1826
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
CAS
2165-19-7
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
EVMPD
SUB07989MIG
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
WIKIPEDIA
GUANOXAN
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
PUBCHEM
16564
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
MERCK INDEX
m5873
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY Merck Index
SMS_ID
100000084476
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
EPA CompTox
DTXSID3046166
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
NCI_THESAURUS
C174589
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
DRUG BANK
DB13211
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
FDA UNII
9V0MRL0R5Y
Created by admin on Fri Dec 15 17:29:42 GMT 2023 , Edited by admin on Fri Dec 15 17:29:42 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY